Patient Reported Outcomes (PRO) to Support Medical Product Labeling Claims
Reimagining patient-centric cancer clinical trials: a multi-stakeholder international coalition | Nature Medicine
Patient-reported outcomes: A new era in clinical research Deshpande PR, Rajan S, Sudeepthi B L, Abdul Nazir C P - Perspect Clin Res
Key considerations to reduce or address respondent burden in patient-reported outcome (PRO) data collection | Nature Communications
The value of patient-reported outcomes in early-phase clinical trials | Nature Medicine
Patient-reported outcomes with first-line nivolumab plus cabozantinib versus sunitinib in patients with advanced renal cell carcinoma treated in CheckMate 9ER: an open-label, randomised, phase 3 trial - The Lancet Oncology
Stepping up the decentralization of clinical trials | McKinsey
The importance of patient-reported outcomes in clinical trials and str | PROM
PDF) Patient-reported outcomes: A new era in clinical research
FDA Patient-Focused Drug Development Guidance Update: Incorporating Patient Experience Data in Clinical Trials
PDF) Patient-reported outcomes: A new era in clinical research
Stepping up the decentralization of clinical trials | McKinsey
Digital clinical trials: a new era - LaingBuisson News
What is an estimand & how does it relate to quantifying the effect of treatment on patient-reported quality of life outcomes in clinical trials? | Journal of Patient-Reported Outcomes | Full Text
Patient-reported outcomes for diabetes and hypertension care in low- and middle-income countries: A scoping review | PLOS ONE
Circulation: Heart Failure | AHA/ASA Journals
Influence of comorbidities and lifestyle factors on health-related quality of life in ALD
